enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Iron polymaltose - Wikipedia

    en.wikipedia.org/wiki/Iron_polymaltose

    Iron(III)-hydroxide polymaltose complex is a medication used to treat iron deficiency / iron deficiency anemia and belongs to the group of oral iron preparations.The preparation is a macromolecular complex, consisting of iron(III) hydroxide (trivalent iron, Fe 3+, Fe(OH) 3 ·H 2 O) and the carrier polymaltose and is available in solid form as a film-coated or chewable tablet and in liquid form ...

  3. The main discussion of these abbreviations in the context of drug prescriptions and other medical prescriptions is at List of abbreviations used in medical prescriptions. Some of these abbreviations are best not used, as marked and explained here.

  4. Anemia of prematurity - Wikipedia

    en.wikipedia.org/wiki/Anemia_of_prematurity

    The infants that received five dosages had higher absolute reticulocyte counts (219,857 mm³) than those infants that received only two dosages (173,361 mm³). However, it was noted that the response to r-EPO typically takes up to two weeks. This study also showed responses between two dosage schedules (two times a week and five times a week).

  5. The FDA approved a new RSV drug for babies and young ... - AOL

    www.aol.com/lifestyle/fda-approved-rsv-drug...

    Three clinical trials found that Beyfortus reduces the risk of RSV in infants and children under 2 years old by 70 to 75%. Beyfortus is expected to be available in the U.S. before the upcoming ...

  6. CDC advisers recommend RSV drug to protect babies ahead of ...

    www.aol.com/news/cdc-advisers-recommend-rsv-drug...

    The drug is an antibody injection given to infants up to 19 months old ahead of RSV season. Next, the CDC director is expected to recommend the shot.

  7. New drug to protect babies, toddlers from RSV gets FDA ... - AOL

    www.aol.com/drug-protect-babies-toddlers-rsv...

    Beyfortus, which will be marketed in the U.S. by Sanofi, is already approved in Canada, Europe and the U.K. Sanofi did The post New drug to protect babies, toddlers from RSV gets FDA approval ...

  8. Pulmonary surfactant (medication) - Wikipedia

    en.wikipedia.org/wiki/Pulmonary_surfactant...

    Pulmonary surfactant is used as a medication to treat and prevent respiratory distress syndrome in newborn babies. [1] Prevention is generally done in babies born at a gestational age of less than 32 weeks. [1] It is given by the endotracheal tube. [1] Onset of effects is rapid. [2] A number of doses may be needed. [2]

  9. New drug to protect babies and toddlers from RSV gets FDA ...

    www.aol.com/news/drug-protect-babies-toddlers...

    U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of American children to the hospital each year.